These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11923228)

  • 1. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
    Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and morphologic analysis of the fluid-conducting meshwork in xenografted cutaneous and primary uveal melanoma.
    Clarijs R; van Dijk M; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3013-20. PubMed ID: 16123395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
    Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
    Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
    Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
    Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
    Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
    Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ
    Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.
    Daniels KJ; Boldt HC; Martin JA; Gardner LM; Meyer M; Folberg R
    Lab Invest; 1996 Jul; 75(1):55-66. PubMed ID: 8683940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma.
    Smetsers TF; van de Westerlo EM; ten Dam GB; Clarijs R; Versteeg EM; van Geloof WL; Veerkamp JH; van Muijen GN; van Kuppevelt TH
    Cancer Res; 2003 Jun; 63(11):2965-70. PubMed ID: 12782604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasculogenic mimicry.
    Folberg R; Maniotis AJ
    APMIS; 2004; 112(7-8):508-25. PubMed ID: 15563313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma.
    Thies A; Mangold U; Moll I; Schumacher U
    J Pathol; 2001 Dec; 195(5):537-42. PubMed ID: 11745688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.
    Hendrix MJ; Seftor EA; Hess AR; Seftor RE
    Nat Rev Cancer; 2003 Jun; 3(6):411-21. PubMed ID: 12778131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.
    Sun B; Zhang S; Zhao X; Zhang W; Hao X
    Int J Oncol; 2004 Dec; 25(6):1609-14. PubMed ID: 15547697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
    Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
    Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased stromal cell-derived factor-1 concentration levels in aqueous from patients with uveal melanoma.
    Zerbini G; Colucci A; Maestroni A; Miserocchi E; Bandello F; Modorati G
    Melanoma Res; 2012 Feb; 22(1):98-9. PubMed ID: 22228277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasculogenic mimicry--potential target for tumor therapy].
    Yue WY; Chen ZP
    Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor angiogensis in uveal melanoma. Role of vascular endothelial growth factor (VEGF)].
    Proniewska-Skretek E; Mariak Z
    Klin Oczna; 2004; 106(4-5):682-5. PubMed ID: 15646494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.